COMMUNIQUÉS West-GlobeNewswire

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
20/08/2026
Revenue for the first half of 2026 increased 29% year-over-year to US$44.5 million (RMB302.2 million), primarily attributable to increased product sales. Expanded executive leadership with appointments of Dr. Faical [...]
Picard Medical Reports Second Quarter 2026 Financial Results
19/08/2026
- Revenue Increases 39% and Net Loss Decreases 16%- Year-to-Date Revenue Increases 50%, with ~$0.9 Million in Gross Profit TUCSON, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“ [...]
Ultragenyx Announces U.S. FDA Approval of GENGLYCOS™ Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying Cause of Glycogen Storage Disease Type Ia (GSDIa)
19/08/2026
GENGLYCOS is the first gene therapy approval, and fifth FDA approval overall, for the company Approval provides a long-awaited first-ever option to reduce the burden of care associated with GSDIa Ultragenyx received a [...]
Solésence Reports Second Quarter 2026 Financial Results
19/08/2026
Quarterly Report Filed on Form 10-Q Company to Host Conference Call at 5:00 p.m. ET Today ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically driven health care [...]
Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
19/08/2026
REYKJAVIK, ICELAND (August 19, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients [...]
Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
19/08/2026
REYKJAVIK, Iceland, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar [...]
Dr. Jacqueline Youtsos Expands Access to Dermatology and Medical Aesthetics with ReNu Medical & Spa in Parsons
19/08/2026
PARSONS, Kan., Aug. 19, 2026 (GLOBE NEWSWIRE) -- {{DATELINECITY_DATE_GLOBENEWSWIRE_BUG} ReNu Medical & Spa is proud to announce the opening of its newest location in Parsons, Kansas, expanding access to high-quality [...]
DNA X, Inc. Reports Second Quarter 2026 Financial Results
19/08/2026
- Strengthened balance sheet with $1.8 million cash from new convertible debt in Q2 and additional $5.0 million through the sale of preferred stock after quarter end -Converted $3.1 million outstanding note to preferred [...]
Regeneron Announces Investor Conference Presentations
19/08/2026
TARRYTOWN, N.Y., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) will webcast management participation as follows: 2026 Wells Fargo Healthcare Conference at 8:45 a.m. ET on Wednesday, [...]
Merit Medical Announces Global Operations Leadership Transition
19/08/2026
SOUTH JORDAN, Utah, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has agreed to join Merit as [...]
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
19/08/2026
HIGH POINT, N.C., Aug. 19, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin , a novel, potential first-in-class oral [...]
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer
19/08/2026
Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector MIAMI, Aug. 19, 2026 (GLOBE NEWSWIRE [...]
Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/08/2026
RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients [...]
Edesa Biotech Announces Proposed Public Offering
19/08/2026
TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno- [...]
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/08/2026
WOBURN, Mass., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a commercial stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of [...]
FDA Authorizes First-of-Its-Kind Robotic Blood Draw Device
19/08/2026
Authorization supports innovative approach to blood collection; may help address growing phlebotomist shortage Silver Spring, Md., Aug. 19, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today authorized [...]
Southern Sky Brands Announces Three New Vape Products in Collaboration with Martin’s in Jackson, Mississippi, Portions of Proceeds to Benefit Veterans Charity
19/08/2026
CANTON, Miss., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Southern Sky Brands is proud to announce the launch of three new vape products created in collaboration with Martin’s, the legendary Mississippi destination known for [...]
What Clinicians Evaluate Before Prescribing Low Dose Naltrexone Online
19/08/2026
Provn connects adults 18 and older with independent, U.S.-licensed clinicians who determine whether compounded low-dose naltrexone is medically appropriate. If prescribed, the strength, titration schedule, and [...]
Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and Clinician-Assessed Flare-ups in a Placebo-controlled Trial in Adults with Fibrodysplasia Ossificans Progressiva (FOP)
19/08/2026
FOP is an ultra-rare genetic disorder characterized by rogue bone formation that infiltrates muscles, tendons, ligaments and other connective tissues, resulting in significant disability Approval based on results from [...]

Pages